STOCK TITAN

Pharmadrug Inc. - $lmlld STOCK NEWS

Welcome to our dedicated page for Pharmadrug news (Ticker: $lmlld), a resource for investors and traders seeking the latest updates and insights on Pharmadrug stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pharmadrug's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pharmadrug's position in the market.

Rhea-AI Summary
PharmaDrug Inc. announces a proposed non-brokered private placement offering of units to raise up to $326,000. Each unit will be comprised of one common share and one-half of one common share purchase warrant. The proceeds will be used for general corporate purposes, and certain insiders of the company may participate in the offering. If insiders participate, the company will be issuing securities to purchasers considered 'related parties.'
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) is a specialty pharmaceutical company focusing on controlled-substances and natural medicines, including psychedelics. The company recently acquired Securedose Synthetics Inc., a private pharmaceutical research and development company. The CEO emphasized the vision and strategy behind the acquisition, aiming to develop biosynthetic versions of drugs to address substance abuse and fentanyl contamination issues. The company also granted stock options to external consultants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
-
Rhea-AI Summary
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) announces the successful completion of a debt restructuring, exchanging $1,219,768 of indebtedness for new unsecured convertible debentures with a principal amount of $1,280,756. The debentures mature in one year, with an option to extend the maturity date up to two times for one-year extensions each time. The debentures bear interest at a rate of 12% per annum payable quarterly and may be converted into units at a price of $0.05 per Unit. The Company has also settled $227,658.03 of indebtedness with certain service providers through the issuance of 4,553,160 common shares at a deemed issue price of $0.05. Additionally, the Company confirms that it will not be issuing additional common share purchase warrants to the holders of the company's secured convertible debentures as referenced in the November 7, 2023 press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.84%
Tags
none
Rhea-AI Summary
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) Grants 6.25M Stock Options at $0.055 Exercise Price
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.13%
Tags
none
-
Rhea-AI Summary
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) has successfully closed the acquisition of Securedose Synthetics Inc., making SecureDose a wholly-owned subsidiary of PharmaDrug.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
none
-
Rhea-AI Summary
PharmaDrug Inc. announces the acquisition of SecureDose Synthetics Inc. The acquisition will be completed in early November 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
70%
Tags
Pharmadrug Inc.

OTC:LMLLD

LMLLD Rankings

LMLLD Stock Data

50.96M
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Toronto